ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 2604

$815K Total Retail Price of All Prescriptions

Rank: 40 out of 2604

695 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 695 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 695 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,370 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 829 438 S3 1 1
LISINOPRIL 575 397 2 3
LEVOTHYROXINE SODIUM 464 339 3 4
METFORMIN HCL 424 311 4 7
LOVASTATIN 423 295 5 24
OMEPRAZOLE 401 244 6 5
METOPROLOL TARTRATE 353 252 7 9
METOPROLOL SUCCINATE 294 205 8 17
WARFARIN SODIUM 279 228 9 13
TRAMADOL HCL 262 153 10 15
SIMVASTATIN 254 195 11 2
GABAPENTIN 224 125 12 12
FUROSEMIDE 224 159 12 8
TRIAMTERENE-HCTZ 209 161 14 55
AMLODIPINE BESYLATE 202 152 15 6
ALENDRONATE SODIUM 183 163 16 29
AZITHROMYCIN 175 139 17 33
IBUPROFEN 162 83 18 32
POTASSIUM CHLORIDE 149 129 19 16
PAROXETINE HCL 138 60 20 62
RANITIDINE HCL 137 79 21 25
ATENOLOL 129 112 22 11
AMOXICILLIN 117 70 23 99
ATORVASTATIN CALCIUM 115 87 24 19
NEXIUM 109 55 25 53
ZOLPIDEM TARTRATE 108 59 26 21
GEMFIBROZIL 107 71 27 87
FENOFIBRATE 107 76 27 69
TRICOR 99 73 29 132
FLUOXETINE HCL 97 30 30 49
GLIPIZIDE XL 95 76 31 144
CYCLOBENZAPRINE HCL 95 27 R 31 43
GLIPIZIDE ER 92 70 33 134
CLOPIDOGREL 89 58 34 39
TAMSULOSIN HCL 84 72 35 30
PROAIR HFA 84 40 35 27
SERTRALINE HCL 78 22 37 23
ISOSORBIDE MONONITRATE ER 74 70 38 38
LOSARTAN POTASSIUM 73 51 39 20
ACETAMINOPHEN-CODEINE 71 44 S3 40 60
PRAVASTATIN SODIUM 71 51 40 14
ADVAIR DISKUS 69 45 42 41
ACTOS 69 54 42 116
BUMETANIDE 68 66 44 70
LANTUS 68 41 44 40
MORPHINE SULFATE ER 66 37 S2 46 58
ESCITALOPRAM OXALATE 66 47 46 73
DIGOXIN 66 39 46 71
SUMATRIPTAN SUCCINATE 65 35 49 245
INSULIN SYRINGE 62 35 50 109
QUINAPRIL HCL 61 44 51 167
CIPROFLOXACIN HCL 61 41 51 59
BENICAR 60 42 53 290
ZETIA 59 59 54 94
TRAZODONE HCL 59 0 54 46
PLAVIX 58 42 56 75
ALLOPURINOL 56 45 57 35
AMITRIPTYLINE HCL 56 27 R 57 82
CYMBALTA 56 22 57 44
KLOR-CON M20 55 34 60 86
OXYCODONE HCL-ACETAMINOPHEN 55 25 S2 60 106
VENLAFAXINE HCL ER 55 14 60 107
CLONIDINE HCL 55 48 60 56
CARISOPRODOL 54 16 R 64 54
CITALOPRAM HBR 54 47 64 18
GLIPIZIDE 53 37 66 51
HYDROCHLOROTHIAZIDE 52 30 67 10
BETAMETHASONE DIPROPIONATE 52 40 67 195
MIRTAZAPINE 51 22 69 52
GLYBURIDE 51 46 R 69 83
DONEPEZIL HCL 51 50 69 28
LANTUS SOLOSTAR 50 43 72 84
MECLIZINE HCL 50 43 72 155
CRESTOR 50 21 72 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.